Shanghai, China

Lijian Cai

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lijian Cai: Innovator in Pharmaceutical Compounds

Introduction

Lijian Cai is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific genetic mutations.

Latest Patents

Lijian Cai holds a patent for a substituted heterocyclic fused cyclic compound. This compound is characterized by its selective inhibitory effect on KRAS gene mutations. The patent also covers the preparation method for this compound and its pharmaceutical applications, particularly in the development of cancer drugs.

Career Highlights

Throughout his career, Lijian Cai has worked with notable companies in the pharmaceutical industry. He has been associated with Genfleet Therapeutics and Zhejiang Genfleet Therapeutics Co., Ltd. His work has focused on innovative solutions for complex medical challenges.

Collaborations

Lijian Cai has collaborated with esteemed colleagues in his field, including Fusheng Zhou and Tao Jiang. These partnerships have contributed to the advancement of research and development in pharmaceutical applications.

Conclusion

Lijian Cai's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions to the development of targeted cancer therapies highlight the importance of research in improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…